EU regulator finds link
The EU regulator found a similar kind of blood clot problem in the J&J vaccine compared to the AstraZeneca vaccine. Despite that, they say it's very rate. All the cases were found in people under 60 years of age and came within three weeks of vaccination. The majority of them were women.
